Overview

A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome

Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Compare Clinical Success and Costs in two Arms
Phase:
Phase 4
Details
Lead Sponsor:
Canyon Pharmaceuticals, Inc.
Treatments:
Argatroban
Desirudin
Heparin
Hirudins